Imunon, Inc.
IMNN Healthcare Biotechnology
Imunon, Inc.’s revenue for fiscal 2022 (year ended December 2022) was $500,000.00. In the quarter to June 2026, EPS grew 71.1% and free cash flow fell 4.24%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
Follow IMNN
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
6.86 | 4.79 | 8.78 | 5.25 |
+8 more quarters Free account |
Other current assets |
1.83 | 1.83 | 1.94 | 2.01 | |
Total current assets |
8.69 | 6.62 | 10.72 | 7.26 | |
Property, Plant, Equpment (Net) |
0.46 | 0.46 | 0.53 | 0.60 | |
Long-term assets (Other) |
5.05 | 0.05 | 0.05 | 0.05 | |
Total non-current assets |
6.30 | 1.40 | 1.56 | 1.73 | |
Total Assets |
14.99 | 8.02 | 12.29 | 8.99 | |
Notes Payable |
1.50 | — | — | — | |
Accounts Payable |
1.62 | 0.96 | 1.39 | 1.13 | |
Total current liabilities |
4.78 | 4.17 | 4.62 | 4.20 | |
Long Term Debt (Total) |
5.53 | — | — | — | |
Non-current Liabilities (Other) |
0.11 | — | — | — | |
Total non-current liabilities |
6.02 | 0.49 | 0.60 | 0.71 | |
Total liabilities |
10.80 | 4.66 | 5.23 | 4.91 | |
Additional Paid In Capital |
430.34 | 428.95 | 428.41 | 421.21 | |
Preferred Stock (Total) |
2.25 | — | — | — | |
Common Stock (Net) |
0.05 | 0.04 | 0.03 | 0.03 | |
Retained Earnings |
(428.36) | (425.55) | (421.30) | (417.08) | |
Treasury Stock |
0.09 | 0.09 | 0.09 | 0.09 | |
Common Equity (Total) |
1.94 | 3.36 | 7.06 | 4.08 | |
Shareholders Equity (Total) |
4.19 | 3.36 | 7.06 | 4.08 | |
Shareholders Equity and Liabilities (Total) |
14.99 | 8.02 | 12.29 | 8.99 | |
Shares (Common) |
4.67 | 3.92 | 3.42 | 2.90 | |
Shareholders Equity (Tangible) |
4.19 | 3.36 | 7.06 | 4.08 | |
Net Debt |
(1.33) | (4.79) | (8.78) | (5.25) | |
Total Debt |
5.53 | — | — | — |